Effectiveness of Glycyrrhizinic Acid (Glizigen) and an Immunostimulant (Viusid) to Treat Anogenital Warts
Open Access
- 14 August 2012
- journal article
- Published by Hindawi Limited in ISRN Dermatology
- Vol. 2012, 1-6
- https://doi.org/10.5402/2012/863692
Abstract
Genital warts are benign proliferations of skin and mucosa caused by the human papillomavirus infection (hereinafter referred to as HPV). It is one of the most common sexually transmitted diseases in the world, whose incidence rate has increased in the last three decades. Current treatment involves the physical destruction of the infected cells. The fact that there are many different types of treatment goes to show that none of them are uniformly effective or directly antiviral. Objective. Demonstrate the efficacy of Glizigen in the III-phase clinical trial combined with a food supplement (VIUSID) formulated to boost the immune system when treating external anogenital warts. Design. 100 patients clinically diagnosed with anogenital lesions were included in the trial and assigned to two groups of 50 individuals. Those from one group where treated with Glizigen and Viusid and those from the other group with 25% podophyllin in alcohol, the results from each were then compared. Results. The combined Glizigen-Viusid treatment was seen to have an 87.5% efficacy rate, which was slightly more than that of the treatment with podophyllin, and there were hardly any adverse reactions reported during the treatment. Conclusions. the combined Glizigen-Viusid treatment was effective in treating genital warts.Keywords
This publication has 14 references indexed in Scilit:
- Topical cidofovir for condylomata acuminata of the genitalia in a 3-year-old child*Journal of the American Academy of Dermatology, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerThe New England Journal of Medicine, 2003
- A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.JNCI Journal of the National Cancer Institute, 2002
- Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention.2002
- Raynaud Phenomenon and Behçet Disease: Diagnosis With Technetium Tc 99m Methylene Diphosphonate Bone Scan and Treatment With Continuous Sympathetic BlockArchives of Dermatology, 2002
- European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital wartsSexually Transmitted Infections, 2000
- Human papillomaviruses: General featuresClinics in Dermatology, 1997
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Successful treatment of a squamous papilloma of the hypopharynx‐esophagus by local injections of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosineJournal of Medical Virology, 1995
- Therapeutic potential of HPMPC as an antiviral drugReviews in Medical Virology, 1993